Evaluation of the efficiency of diagnostic regimens for enterohemorrhagic escherichiasis. Etiological verification of hemolytic uremic syndrome in the Russian Federation


Cite item

Full Text

Abstract

AIM. To evaluate the practical efficiency of the diagnostic algorithms for enterohemorrhagic escherichiasis, which are laid down by the current normative documents of the Russian Federation. MATERIALS AND METHODS. The investigators estimated the prevalence of enterohemorrhagic Escherichia coli (EHEC) infection in children with the symptoms of acute enteric infections (AEI) (archival samples) and in those aged less than 5 years with fatal evolution and a history of diarrhea and hemolytic uremic syndrome (HUS), evaluated the efficiency of bacteriological tests in HUS patients with acute EHEC infection, and comparatively analyzed the documents regulating EHEC surveillance in the Russian Federation and other countries. RESULTS. Nucleic acid amplification assay showed that the prevalence of EHEC among the hospitalized children was 1.2% (27/1269), the anamnestic registration rate for HUS among the children with fatal outcomes in AEI was 20% (5/25). The efficiency of the bacteriological diagnosis of enterohemorrhagic escherichiasis in the archival samples corresponding to the early stages of the disease in the presence of diarrhea and at the HUS development stage was 48.1% (13/27) and 6.1% (2/33), respectively. There was a potential to enhance the efficiency of the normative documents regulating the etiological diagnosis of EHEC infection in the Russian Federation. CONCLUSION. The given data substantiate the necessity of including the etiological diagnosis of EHEC infection in the list of mandatory screening studies in children with sporadic cases of hemocolitis at the early stages of the disease.

About the authors

A T Podkolzin

ФБУН "ЦНИИ эпидемиологии" Роспотребнадзора, Москва

Email: apodkolzin@pcr.ru
111123 Москва, ул. Новогиреевская, 3а

T A Konovalova

ФБУН "ЦНИИ эпидемиологии" Роспотребнадзора, Москва

O A Veselova

ФБУН "ЦНИИ эпидемиологии" Роспотребнадзора, Москва

References

  1. Scallan E., Hoekstra R.M., Angulo А. et al. Foodborne illness acquired in the United States - Major pathogens. Emerg Infect Dis 2011; 17: 7-14.
  2. Hale C.R., Scallan E., Cronquist Е. et al. Estimates of enteric illness attributable to contact with animals and their environments in the United States. Clin Infect Dis 2012; 54: 472-479.
  3. Johnson K.E., Thorpe C.M., Sears C.L. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 2006; 43: 1587-1595.
  4. Kaspar C., Doyle M.E., Archer J. White paper on non-O157:H7 Shiga toxinproducing E. coli from meat and non-meat sources. 2010. http://fri.wisc.edu/docs/pdf/ FRI_Brief_NonO157STEC_4_10.pdf
  5. Griffin P.M., Tauxe R.V. The epidemiology of infections caused by Escherichia coli O157: H 7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60-98.
  6. Gyles C.L. Shiga toxin-producing Escherichia coli: An overview. J Animal Scie 2007; 85: 45-62.
  7. Salvadori M., Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2 (3): 56-76.
  8. Gould L.H., Bopp C., Strockbine N. et al. Recommendations for Diagnosis of Shiga Toxin-Producing Escherichia coli Infections by Clinical Laboratories. MMWR Recomm Rep 2009; 58 (RR-12): 1-14.
  9. Подколзин А.Т., Петухов Д.Н., Коновалова Т.А. Рекомендации РЦКИ: Оптимизация лабораторных методов исследований в надзоре за энтерогеморрагическими E. coli (EHEC) http://www.epid-oki.ru/cont/analit_pism/Optimizacija_laboratornyh_metodov_issledovanij_v_nadzore_za_jenterogemorragicheskimi_ E_coli_(EHEC).pdf
  10. Guidance for Public Health Laboratories: Isolation and Characterization of Shiga toxin-producing Esherichia coli (STEC) from Clinical Specimens [PDF - 102 pages] http://www.aphl.org/AboutAPHL/publications/Documents/FS_2012April_Guidance-for-PHLs-Isolation-and-Characterization-of-Shiga-Toxin-Producing-Escherichia-coli-STEC-from-Clinical.pdf

Copyright (c) 2014 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies